Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Polymerase I and Transcript Release Factor (PTRF) (C-Term) Peptid

PTRF Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN5511461
  • Target Alle PTRF Produkte
    PTRF (Polymerase I and Transcript Release Factor (PTRF))
    Protein Region
    C-Term
    Spezies
    Human
    Quelle
    • 1
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB)
    Sequenz
    EESRAERIKR SGLRRVDDFK KAFSKEKMEK TKVRTRENLE KTRLKTKENL
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti-PTRF Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    PTRF (Polymerase I and Transcript Release Factor (PTRF))
    Hintergrund
    This gene encodes a protein that enables the dissociation of paused ternary polymerase I transcription complexes from the 3' end of pre-rRNA transcripts. This protein regulates rRNA transcription by promoting the dissociation of transcription complexes and the reinitiation of polymerase I on nascent rRNA transcripts. This protein also localizes to caveolae at the plasma membrane and is thought to play a critical role in the formation of caveolae and the stabilization of caveolins. This protein translocates from caveolae to the cytoplasm after insulin stimulation. Caveolae contain truncated forms of this protein and may be the site of phosphorylation-dependent proteolysis. This protein is also thought to modify lipid metabolism and insulin-regulated gene expression. Mutations in this gene result in a disorder characterized by generalized lipodystrophy and muscular dystrophy.

    Alias Symbols: PTRF, FKSG13,

    Protein Size: 390
    Gen-ID
    284119
    NCBI Accession
    NP_036364
    UniProt
    Q6NZI2
Sie sind hier:
Kundenservice